BOSTON SCIENTIFIC CORP Deferred Revenue 2018-2025 | BSX
Beta
What is deferred revenue?
Deferred revenue represents payments received in advance for goods or services that have not yet been delivered to customers.
What is BOSTON SCIENTIFIC CORP's current deferred revenue?
BOSTON SCIENTIFIC CORP (BSX) annual deferred revenue for 2025 was $313.0M, a 2.29% increase from 2024. BOSTON SCIENTIFIC CORP deferred revenue for the quarter ending December 31, 2025 was $313.0M.
What was BOSTON SCIENTIFIC CORP's deferred revenue in 2024?
BOSTON SCIENTIFIC CORP annual deferred revenue for 2024 was $306.0M, a 15.04% increase from 2023.
What was BOSTON SCIENTIFIC CORP's deferred revenue in 2023?
BOSTON SCIENTIFIC CORP annual deferred revenue for 2023 was $266.0M, a 20.91% increase from 2022.
What is BOSTON SCIENTIFIC CORP's 5-year deferred revenue CAGR?
BOSTON SCIENTIFIC CORP deferred revenue grew at a compound annual growth rate (CAGR) of 17.80% from FY2020 to FY2025, going from $138.0M to $313.0M over 5 years.
Deferred Revenue History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Growing
CAGR+17.8%
FY2020
$138.0M
→
FY2025
$313.0M
1819202122232425
5 years selected
Company: BOSTON SCIENTIFIC CORPTicker: BSXSector: HealthcareIndustry: Surgical & Medical Instruments & ApparatusView company profile →